By Ana Espino | Published on January 14, 2026 | 3 min read
Alcohol use is a
major risk factor
for morbidity and mortality worldwide, contributing to more than
60 diseases,
including cardiovascular diseases, cancers, liver cirrhosis, and
neuropsychiatric disorders. Despite this well-documented burden,
international
recommendations regarding
“moderate” levels of alcohol consumption remain
controversial, sometimes conveying contradictory messages about potential
protective effects of low doses. This ambiguity undermines the definition of
safe consumption thresholds.
One of the major challenges lies in
the comparative assessment of the alcohol-attributable burden according to sex,
age, world regions, and levels of consumption. The objective of this study,
published in The Lancet, was to analyze alcohol consumption and its
health impact in 195 countries between 1990 and 2016, using data from the
Global Burden of Disease (GBD) study, in order to better inform public health
policies.
Zero drinks, zero risk?
This
comparative modeling study is
based on data from the
Global Burden of Disease Study 2016. It integrates
694
data sources on alcohol consumption,
592 studies on risk relationships, and
models effects on
23 alcohol-attributable conditions. The analysis relies on a
comparative risk assessment approach, combining levels of consumption, relative
risks, prevalence estimates, and mortality data.
The results show that alcohol is
responsible for
2.8 million deaths per year (i.e., 1 in 10 deaths among
individuals aged 15–49 years). Among
young adults, alcohol is the
leading cause
of premature mortality, largely driven by injuries, violence, suicides, and
tuberculosis. Contrary to widespread beliefs,
no level of alcohol consumption
is risk-free for overall health. Even low levels of consumption are associated
with a net increase in risk, particularly for cancers. The
level of consumption
associated with the lowest risk is… zero. Eastern Europe and Latin America
record the highest levels of consumption, while North Africa, the Middle East,
and South Asia show the lowest levels.
Changing the rules of the game?
Alcohol is a
major, avoidable risk
factor, associated with high morbidity and mortality, particularly among young
adults. The main challenge is to
reconcile public health messaging with
epidemiological evidence in a context where alcohol consumption is culturally
valued. This study aimed to q
uantify the global impact of alcohol on health
using the most recent and comprehensive data available.
It robustly demonstrates that the
level of consumption associated with minimal risk is zero, contradicting the
notion of a protective effect of the “glass of wine per day.” However, some
limitations remain: exposure data are heterogeneous across regions; potential
cardiovascular benefits have not been completely excluded in individuals over
50 years of age; and individual differences (genetics, comorbidities) are not
fully accounted for.
Future perspectives include
more
coherent public health campaigns, policies to reduce access, clear labeling,
better consideration of cumulative risk in guidelines, and further research on
differential effects by age, sex, and high-risk populations.
Read next: Microbiota & Alcohol: toward a new treatment?
About the author – Ana EspinoPhD in Immunology, specialized in Virology
As a scientific writer, Ana is passionate about bridging the gap between research and real-world impact. With expertise in immunology, virology, oncology, and clinical studies, she makes complex science clear and accessible. Her mission: to accelerate knowledge sharing and empower evidence-based decisions through impactful communication.